Jameka Hill is the Senior Director, Clinical Trial Health Equity at Moderna. Within this role she is leading patient advocacy and clinical trial diversity efforts to deepen patient advocacy and community health partnerships with organizations working to meet the needs of medically underserved populations, while also embedding into Moderna’s operating model patient focused initiatives and processes that ensure medically underrepresented groups and vulnerable populations are included in the drug development process and represented in Moderna clinical trials.
For over 20 years, Jameka has focused exclusively on improving access to clinical trials as a care option for women, older adults, racial and ethnic minority groups, patients living with rare diseases, and vulnerable populations including pregnant women and pediatrics. Jameka is an avid health literacy and community engagement advocate who strongly believes in the importance of collaborating with internal stakeholders and external thought leaders to improve heath equity around the world.
Jameka completed her B.S. degree at the University of California, Berkeley in 2001 and joined Moderna in July 2020.
15-Jun-2023Central 5Inclusivity and inequalities: the future of clinical trials